Found 75 clinical trials
Safety & Efficacy Study of Relamorelin in Diabetic Gastroparesis
This trial studies the safety and effectiveness of an experimental drug for diabetic gastroparesis.
- 62 views
- 13 Aug, 2019
- 1 location
The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States
experimental drug or therapy, and enrollment in CHRONICLE will not affect your prescribed treatment. Your involvement can last 5 years or longer; however, you are free to withdraw from the study at any
- 71 views
- 09 May, 2019
- 1 location
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
adequate response to approved oral treatments. Troriluzole is an "investigational" or experimental drug, which means that the drug has not been approved by regulatory authorities for use outside of research
- 0 views
- 05 Apr, 2021
- 1 location
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
- 100 views
- 23 Nov, 2020
- 1 location
A Phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem cells (eASC), for the treatment of complex perianal fistula(s) in patients with Crohn's disease over a period of 24 weeks and a follow-up period up to 52 weeks. ADMIRE-CD II Study.
The purpose of this study is to evaluate the safety, tolerability and effectiveness of an experimental drug called Cx601 (stem cells) to treat perianal fistulas in subjects with Crohn’s
- 32 views
- 11 Jun, 2020
- 1 location
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)
This is a study involving an investigational (experimental) drug called sitravatinib, given in combination with the immunotherapy nivolumab (also known as OPDIVO®). Sitravatinib
- 80 views
- 02 Jun, 2021
- 36 locations
Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients
Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients
- 110 views
- 08 Nov, 2020
- 1 location
Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
MAD0004J08, the experimental drug, is a potent neutralizing IgG1 monoclonal antibody (mAb) targeting the spike protein of SARS-CoV-2. MAD0004J08 blocks viral attachment and entry into human
- 0 views
- 22 Jul, 2021
- 14 locations
Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
- 0 views
- 20 May, 2021
- 4 locations